Risk of Atrial Fibrillation and Stroke among Taiwan Osteoporosis Population: Alendronate vs. Calcitonin/Raloxifene Users

被引：0
|
作者：
Lin, Tzu-Chieh [1 ]
Yang, Yea-Huei Kao [1 ,2 ]
Yang, Chyun-Yu [3 ]
机构：
[1] Natl Cheng Kung Univ, Coll Med, Inst Biopharmaceut Sci, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Dept Orthoped, Tainan 70101, Taiwan
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2011年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
690
引用
收藏
页码：S299 / S300
页数：2
相关论文
共 50 条
  • [1] Risk of Venous Thromboembolism among Taiwan Osteoporosis Population: Alendronate vs Raloxifene Users
    Lin, Tzu-Chieh
    Lee, Cheng-Han
    Yang, Yea-Huei Kao
    Yang, Chyun-Yu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 191 - 191
  • [2] Osteoporosis treatment and atrial fibrillation: alendronate versus raloxifene
    Huang, Weng-Foung
    Tsai, Yi-Wen
    Wen, Yu-Wen
    Hsiao, Fei-Yuan
    Kuo, Ken N.
    Tsai, Chia-Rung
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2010, 17 (01): : 57 - 63
  • [3] Alendronate vs. calcitonin: 2-year treatment of osteoporosis in postmenopausal women
    Rosen, CJ
    Schnitzer, TJ
    McClung, M
    Miller, PD
    Wang, L
    Vanaman, LK
    Yates, J
    Melton, ME
    Palmisano, J
    BONE, 2001, 28 (05) : S226 - S226
  • [4] Stroke risk in an elderly population with atrial fibrillation
    Feinberg, WM
    Kronmal, RA
    Newman, AB
    Kraut, MA
    Bovill, EG
    Cooper, L
    Hart, RG
    JOURNAL OF GENERAL INTERNAL MEDICINE, 1999, 14 (01) : 56 - 59
  • [5] Stroke risk in an elderly population with atrial fibrillation
    William M. Feinberg
    Richard A. Kronmal
    Anne B. Newman
    Michael A. Kraut
    Edwin G. Bovill
    Lawton Cooper
    Robert G. Hart
    Journal of General Internal Medicine, 1999, 14 : 56 - 59
  • [6] Patient-centered Assessment Of Risk Of Stroke Vs. Bleeding In Patients With Atrial Fibrillation
    Sargsyan, Davit
    Duan, Yajie
    Kostis, William J.
    Ananth, Cande
    Kostis, John B.
    Cabrera, Javier
    CIRCULATION, 2021, 144
  • [7] Cost-effectiveness of Direct Oral Anticoagulant vs. Warfarin Among Atrial Fibrillation Patients With Intermediate Stroke Risk
    Choi, Ju Hee
    Kim, Woojin
    Kim, Yun Tae
    Cho, Jaelim
    Shin, Seung Yong
    Kim, Changsoo
    Kim, Jin-Bae
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [8] Edoxaban vs. Warfarin for Stroke Prevention for Patients with Atrial Fibrillation
    Diener, H. C.
    AKTUELLE NEUROLOGIE, 2014, 41 (04) : E52 - E52
  • [9] RISK OF BLEEDING VS STROKE IN ESRD PATIENTS WITH ATRIAL FIBRILLATION
    Marroquin, Maria
    Sy, John
    Potukuchi, Praveen
    Agarwal, Manyoo
    Kovesdy, Csaba
    Kalantar-Zadeh, Kamyar
    Streja, Elani
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2019, 73 (05) : 704 - 704
  • [10] Risk of atrial fibrillation among bisphosphonate users: a multicenter, population-based, Italian study
    L. Herrera
    I. Leal
    F. Lapi
    M. Schuemie
    V. Arcoraci
    F. Cipriani
    E. Sessa
    A. Vaccheri
    C. Piccinni
    T. Staniscia
    A. Vestri
    M. Di Bari
    G. Corrao
    A. Zambon
    D. Gregori
    F. Carle
    M. Sturkenboom
    G. Mazzaglia
    G. Trifiro
    Osteoporosis International, 2015, 26 : 1499 - 1506
12345